Back to search
FDAFDA · Food and drugs·Recall number D-1131-2017

Latanoprost PF Solution, 0.005%, Ophthalmic Drops in Sterile 5ml Bottles, Compounded for a licensed professional or patient use, imprimisRx, Irvine, CA

Published September 13, 2017 · Recall initiated: June 23, 2017

Summary

FDA records drug Class II recall D-1131-2017, published September 13, 2017 and initiated June 23, 2017. Recalling firm: ImprimisRx CA, Inc., dba ImprimisRx; Status: Terminated; Reported quantity: 19 bottles; Lot: 0404017@32B, 10/01/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
ImprimisRx CA, Inc., dba ImprimisRx
Distributor
Nationwide
Lot
0404017@32B, 10/01/2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Latanoprost PF Solution, 0.005%, Ophthalmic Drops in Sterile 5ml Bottles, Compounded for a licensed professional or patient use, imprimisRx, Irvine, CA recalled?

Yes. FDA published recall D-1131-2017 on September 13, 2017. Reported hazard: Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit